The airway neuro-immune axis as a therapeutic target in allergic airway diseases

Respir Res. 2024 Feb 8;25(1):83. doi: 10.1186/s12931-024-02702-8.

Abstract

Recent evidence has increasingly underscored the importance of the neuro-immune axis in mediating allergic airway diseases, such as allergic asthma and allergic rhinitis. The intimate spatial relationship between neurons and immune cells suggests that their interactions play a pivotal role in regulating allergic airway inflammation. Upon direct activation by allergens, neurons and immune cells engage in interactions, during which neurotransmitters and neuropeptides released by neurons modulate immune cell activity. Meanwhile, immune cells release inflammatory mediators such as histamine and cytokines, stimulating neurons and amplifying neuropeptide production, thereby exacerbating allergic inflammation. The dynamic interplay between the nervous and immune systems suggests that targeting the neuro-immune axis in the airway could represent a novel approach to treating allergic airway diseases. This review summarized recent evidence on the nervous system's regulatory mechanisms in immune responses and identified potential therapeutic targets along the peripheral nerve-immune axis for allergic asthma and allergic rhinitis. The findings will provide novel perspectives on the management of allergic airway diseases in the future.

Keywords: Airway neuro-immune axis; Allergic rhinitis; Asthma; Therapeutic target.

Publication types

  • Review

MeSH terms

  • Asthma* / drug therapy
  • Humans
  • Inflammation
  • Neuroimmunomodulation
  • Neuropeptides*
  • Respiration Disorders*
  • Respiratory System
  • Rhinitis, Allergic* / drug therapy

Substances

  • Neuropeptides